Brain Advance Access originally published online on October 17, 2006
Brain 2006 129(12):3277-3289; doi:10.1093/brain/awl287
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Altered expression of 
3-containing GABAA receptors in the neocortex of patients with focal epilepsy
1 Institute of Pharmacology and Toxicology, University of Zurich Zurich, Switzerland 2 Department of Neurosurgery, University Hospital Zurich Zurich, Switzerland 3 Department of Neurology, University Hospital Zurich Zurich, Switzerland 4 Department of Neurology, University Hospital and Medical School of Geneva Geneva, Switzerland 5 INSERM Faculty of Medicine Strasbourg, France 6 Service de Neurochirurgie, Hôpitaux Universitaires de Strasbourg Strasbourg, France 7 Present addresses: Swiss Epilepsy Center Zurich, Switzerland 8 The Mental Retardation Research Center, David Geffen School of Medicine, University of California Los Angeles, CA, USA
Correspondence to: Dr Fabienne Loup, Swiss Epilepsy Center, Bleulerstrasse 60, CH-8008 Zurich, Switzerland E-mail: loupf{at}pharma.unizh.ch
Impaired transmission in GABAergic circuits is thought to contribute to the pathogenesis of epilepsy. Although it is well established that major reorganization of GABAA receptor subtypes occurs in the hippocampus of patients with medically refractory temporal lobe epilepsy (TLE), it is unclear whether this disorder is also associated with alterations in GABAA receptor subtypes in the neocortex. Here we have investigated immunohistochemically the subunit composition and neocortical distribution of three major GABAA receptor subtypes using antibodies specifically recognizing the subunits 
1, 2, 3, ß2/3 and 
2. Cortical tissue was obtained at surgery from patients with TLE and hippocampal sclerosis (HS; n = 9), TLE associated with neocortical lesions (non-HS; n = 12) and frontal lobe epilepsy (FLE; n = 5), with post-mortem samples serving as controls (n = 4). A distinct laminar and neuronal expression pattern of the -subunit variants was found across the neocortical regions examined in the temporal and frontal lobes in both control and patient tissue samples. In the five patients with FLE, GABAA receptor subunit staining was unchanged as compared to controls. In patients with TLE we observed a marked decrease in 3-subunit staining in the superficial neocortical layers (I–III), but no change in the deep layers (V and VI) or in the expression pattern of the 1 and 2-subunits. Reduced expression in 3-containing GABAA receptors was detected in six out of nine patients of the HS group and four out of twelve patients of the non-HS group. Histopathological changes were present in eight out of the ten patients with decreased 3-subunit staining. The selective reduction in 3-containing GABAA receptors was confirmed using semiquantitative measurements of optical density (OD). The specific changes unique to 3-subunit expression in the superficial neocortical layers of patients with TLE suggest that this subtype is of particular significance in the reorganization of cortical GABAergic systems in focal epilepsy.
Key Words: cerebral cortex; GABA; human; seizures; temporal lobe epilepsy
Abbreviations: ECoG, electrocorticography; FLE, frontal lobe epilepsy; HS, hippocampal sclerosis; OD, optical density; TLE, temporal lobe epilepsy
Received May 30, 2006. Revised September 10, 2006. Accepted September 11, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Loup, F. Picard, Y. Yonekawa, H.-G. Wieser, and J.-M. Fritschy Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy Brain, September 1, 2009; 132(9): 2449 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Bernhardt, K. J. Worsley, H. Kim, A. C. Evans, A. Bernasconi, and N. Bernasconi Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy Neurology, May 19, 2009; 72(20): 1747 - 1754. [Abstract] [Full Text] [PDF]
|
|